LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC

Yunshi Cai,Tao Lyu,Hui Li,Chang Liu,Kunlin Xie,Lin Xu,Wei Li,Hu Liu,Jiang Zhu,Yinghao Lyu,Xuping Feng,Tian Lan,Jiayin Yang,Hong Wu
DOI: https://doi.org/10.1186/s13046-022-02544-6
2022-12-07
Abstract:Hepatocellular carcinoma (HCC) is the world's third leading cause of cancer-related death; due to the fast growth and high prevalence of tumor recurrence, the prognosis of HCC patients remains dismal. Long non-coding RNA CEBPA-DT, a divergent transcript of the CCAAT Enhancer Binding Protein Alpha (CEBPA) gene, has been shown to participate in multiple tumor progression. However, no research has established its cancer-promoting mechanism in HCC yet.
oncology
What problem does this paper attempt to address?